Skip to main content

Corporate insider profile

Paul L Berns Insider Trades

Paul L Berns has reported 3 open-market purchases on SEC Form 4 and is a net buyer of $62,999,992 across 3 companies. The most recent open-market transaction was reported on Nov 4, 2026. Source: SEC Form 4 filings.

Latest reported as Corporate insider of Lyell Immunopharma, Inc. (LYEL).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
3
Reported companies
3
Net open-market value
$62,999,992
Latest transaction
Nov 4, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Nov 4, 2026Lyell Immunopharma, Inc. (LYEL)Corporate insiderOpen Market Purchase2,321,262$10.77$24,999,992
Nov 2, 2026Aspen Neuroscience, Inc. (ASPE)10% OwnerOpen Market Purchase1,200,000$15.00$18,000,000
Jun 22, 2026Kardigan, Inc. (KARD)Corporate insiderOpen Market Purchase1,250,000$16.00$20,000,000

Common questions

Paul L Berns insider trading FAQ

Is Paul L Berns buying or selling stock?
Across all SEC Form 4 open-market filings on record, Paul L Berns is a net buyer of $62,999,992, with 3 open-market purchases reported. The latest transaction was reported on Nov 4, 2026.
Which companies does Paul L Berns report insider trades for?
Paul L Berns has reported open-market trades in Lyell Immunopharma, Inc. (LYEL), Aspen Neuroscience, Inc. (ASPE), Kardigan, Inc. (KARD). The latest SEC-reported relationship is Corporate insider of Lyell Immunopharma, Inc. (LYEL).
Where does Paul L Berns's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1202769, and refreshes this page daily.